EQT Corporation Common Stock vs Medtronic PLC — how do they compare? EQT Corporation Common Stock trades at $52.81 (market cap $33.11B), while Medtronic PLC trades at $88.13 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 3.4× EQT Corporation Common Stock's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold EQT Corporation Common Stock for 0 Days and Medtronic PLC for 63 Days on average.
| EQT | MDT | |
|---|---|---|
Market Cap | $33.11B | $112.24B |
Volume | 7,642,959 | 105,663,236 |
Sector | Energy | Health |
52-Week High | $67.93 | $105.35 |
52-Week Low | $48.56 | $73.75 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $38.66B | $131.58B |
Dividend Yield | 1.25% | 3.28% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.
Read more on EQT →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →